simendan has been researched along with Anemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Büyüklü, M; Kürüm, AT; Set, T; Tatlý, E | 1 |
| Farmakis, D; Kremastinos, DT; Parissis, JT | 1 |
2 other study(ies) available for simendan and Anemia
| Article | Year |
|---|---|
Effects of levosimendan on TNF-alpha, BNP and MMP-1 in patients with heart failure with anemia.
Topics: Aged; Anemia; Cardiotonic Agents; Chi-Square Distribution; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Matrix Metalloproteinase 1; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Simendan; Statistics, Nonparametric; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Anti-inflammatory effects of levosimendan in decompensated heart failure: impact on weight loss and anemia.
Topics: Anemia; Anti-Inflammatory Agents; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Weight Loss | 2005 |